Suppr超能文献

肝移植中门静脉管道的二十年随访

Twenty years' follow-up of portal vein conduits in liver transplantation.

作者信息

Nikitin Dmitriy, Jennings Linda W, Khan Tariq, Vasani Sugam, Ruiz Richard, Sanchez Edmund Q, Chinnakotla Srinath, Levy Marlon F, Goldstein Robert M, Klintmalm Goran B

机构信息

Baylor Regional Transplant Institute, Dallas/Ft. Worth, TX 75246, USA.

出版信息

Liver Transpl. 2009 Apr;15(4):400-6. doi: 10.1002/lt.21698.

Abstract

Portal vein problems remain a formidable challenge in liver transplantation. In select situations, a portal vein conduit can provide a solution. No long-term results have been reported. This study was designed to assess the impact of portal vein conduits on graft survival after liver transplantation and the safety of portal vein conduits and to establish the long-term results (up to 20 years) of portal vein conduits. Data from 2370 adult liver transplants were prospectively collected into a computerized research database and analyzed. All portal vein conduits were constructed from the donor iliac vein obtained at the liver retrieval. Portal vein conduits were required in 35 (1.5%) first transplants. The long-term (up to 20 years of follow-up) graft survival after liver transplantation using portal vein conduits was excellent and comparable to that of the control group. The graft survival was 65% with the conduit versus 66% without the conduit at 5 years of follow-up, 58% versus 51% at 10 years, and 48% versus 35% at 15 years. There was a higher rate (8.6% versus 1.4%) of portal vein thrombosis after the portal vein conduit, and the majority occurred in the first 3 months after transplantation. For the same time period, there was no statistically significant difference in graft survival or patient survival for the retransplants with and without portal vein conduits. There was no statistically significant difference in graft survival or patient survival for the transplants with portal vein conduits and with portal vein thrombendvenectomy. In conclusion, portal vein conduits can be used safely for liver transplantation with no negative impact on long-term graft survival or patient survival. Despite the higher rate of portal vein thrombosis in the immediate postoperative period, excellent long-term results can be obtained.

摘要

门静脉问题在肝移植中仍然是一个巨大的挑战。在某些特定情况下,门静脉导管可以提供一种解决方案。目前尚未有长期结果的报道。本研究旨在评估门静脉导管对肝移植后移植物存活的影响以及门静脉导管的安全性,并确立门静脉导管的长期结果(长达20年)。前瞻性收集了2370例成人肝移植的数据并录入计算机化研究数据库进行分析。所有门静脉导管均由肝获取时取得的供体髂静脉构建而成。35例(1.5%)首次移植需要使用门静脉导管。使用门静脉导管进行肝移植后的长期(长达20年随访)移植物存活率极佳,与对照组相当。随访5年时,使用导管组的移植物存活率为65%,未使用导管组为66%;随访10年时,分别为58%和51%;随访15年时,分别为48%和35%。门静脉导管置入后门静脉血栓形成的发生率较高(8.6% 对比1.4%),且大多数发生在移植后的前3个月。在同一时期,再次移植时使用和未使用门静脉导管的移植物存活率或患者存活率无统计学显著差异。使用门静脉导管和进行门静脉血栓内膜切除术的移植患者的移植物存活率或患者存活率也无统计学显著差异。总之,门静脉导管可安全用于肝移植,对长期移植物存活或患者存活无负面影响。尽管术后早期门静脉血栓形成的发生率较高,但仍可获得出色的长期结果。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验